Friday, March 8, 2013

OncoMed Pharmaceuticals Initiates Phase 1 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-52M51 (Anti-Notch1) in Solid Tumors

Read about how OncoMed Pharmaceuticals Initiates Phase 1 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-52M51 (Anti-Notch1) in Solid Tumors.

http://bionews-tx.com/news/oncomed-pharmaceuticals-initiates-phase-1-clinical-trial-of-anti-cancer-stem-cell-therapeutic-omp-52m51-anti-notch1-in-solid-tumors/
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)